We are live on ! Find out more
CLRBZ

Cellectar Biosciences, Inc. Series A Warrants
CLRBZ

Delisted

CLRBZ was delisted on the 16th of April, 2021.

Back to rankings

2 hedge funds and large institutions have $92K invested in Cellectar Biosciences, Inc. Series A Warrants in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

12% less capital invested

Capital invested by funds: $104K → $92K (-$12K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$95.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
1
CVI Holdings
Delaware
$87K +$102K +207,500 New
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$5K -$95.8K -195,528 -94%

CLRBZ Hedge Fund Activity: Q1 2018 in Review

2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) for Q1 2018, worth a combined $92K — down 12% from $104K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new CLRBZ positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest seller was Susquehanna International Group, cutting an estimated $95.8K.

  • 2 institutional investors held Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) as of Q1 2018, up from 1 in Q4 2017.
  • Funds reported $92K of Cellectar Biosciences, Inc. Series A Warrants stock for Q1 2018, down 12% quarter-over-quarter.
  • 1 fund opened new Cellectar Biosciences, Inc. Series A Warrants positions in Q1 2018 and 0 closed out, a net change of +1 holder.
  • The largest Cellectar Biosciences, Inc. Series A Warrants seller in Q1 2018 was Susquehanna International Group, an estimated $95.8K sold.

Based on aggregated 13F filings for Q1 2018.